Xenopus-derived glucagon-like peptide-1 and polyethylene-glycosylated glucagon-like peptide-1 receptor agonists: long-acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities.
Jing HanYingying FeiFeng ZhouXinyu ChenYing ZhangLin LiuJunjie FuPublished in: British journal of pharmacology (2018)
Peptide 33 is a promising long-acting type 2 diabetes therapeutic deserving further investigation.